ChartRow logo
PeersMDTSYKBSXEWAMGNSTE
Share this page

ABT financial statements

The full income statement, balance sheet, and cash-flow statement for Abbott Laboratories (ABT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 1.74B2024-09 1.73B2024-12 1.73B2025-03 1.74B2025-06 1.74B2025-09 1.74B2025-12 1.74B2026-03 1.74B2026-06 1.73B-0.5% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue44.3B+5.7%42.0B+4.6%40.1B-8.1%43.7B+1.3%43.1B+24.5%
Cost of revenue19.3B+3.3%18.7B+4.1%18.0B-6.1%19.1B+3.3%18.5B+23.6%
Research & development2.94B+3.4%2.84B+3.8%2.74B-5.1%2.89B+5.3%2.74B+13.3%
Selling, general & administrative12.3B+5.4%11.7B+6.8%10.9B-2.7%11.2B-0.7%11.3B+16.8%
Amortization of intangibles1.68B-10.4%1.88B-4.5%1.97B-2.3%2.01B-1.7%2.05B-4.0%
Provision for credit losses75.0M+23.0%61.0M+134.6%26.0M+333.3%6.00M-88.2%51.0M-42.0%
Operating income8.05B+18.0%6.83B+5.4%6.48B-22.5%8.36B-0.7%8.43B+57.3%
Interest expense493M-11.8%559M-12.2%637M+14.2%558M+4.7%533M-2.4%
Interest & investment income308M-10.5%344M-10.6%385M+110.4%183M+325.6%43.0M-6.5%
Other non-operating income548M+45.7%376M-21.5%479M+49.2%321M+15.9%277M+168.9%
Pre-tax income8.47B+20.7%7.01B+5.2%6.66B-19.8%8.31B+1.2%8.21B+65.3%
Income tax1.94B+130.4%-6.39B-779.0%941M-31.5%1.37B+20.4%1.14B+129.4%
6.52B-51.3%13.4B+134.2%5.72B-17.5%6.93B-2.0%7.07B+57.3%
Discontinued operations———0.000.00-100.0%
Net income to common6.50B-51.5%13.4B+135.1%5.70B-17.5%6.91B-1.9%7.04B+57.4%
$3.72-51.3%$7.64+134.4%$3.26-16.6%$3.91-0.8%$3.94+57.6%
EPS (basic)$3.73-51.4%$7.67+133.8%$3.28-16.8%$3.94-0.8%$3.97+57.5%
Weighted-avg shares (basic)1.74B+0.1%1.74B+0.0%1.74B-0.7%1.75B-1.2%1.77B+0.1%
Weighted-avg shares (diluted)1.75B+0.0%1.75B-0.1%1.75B-0.9%1.76B-1.4%1.79B+0.2%
Dividends per share$2.40+7.1%$2.24+7.7%$2.08+8.3%$1.92+5.7%$1.82+25.6%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
26.0B+9.9%23.7B+4.3%22.7B-10.1%25.2B+4.1%24.2B+18.6%
Cash & equivalents8.52B+11.9%7.62B+10.4%6.90B-30.2%9.88B+0.8%9.80B+43.3%
Short-term investments417M+18.8%351M-8.4%383M+33.0%288M-36.0%450M+45.2%
Accounts receivable7.93B+14.5%6.92B+5.5%6.57B+5.6%6.22B-4.1%6.49B+1.1%
Inventory6.49B+4.7%6.19B-5.7%6.57B+6.4%6.17B+19.7%5.16B+2.9%
86.7B+6.5%81.4B+11.2%73.2B-1.6%74.4B-1.0%75.2B+3.6%
Property, plant & equipment11.8B+10.9%10.7B+5.0%10.2B+10.8%9.16B+2.3%8.96B-0.8%
Operating lease right-of-use1.13B+4.7%1.07B-4.2%1.12B+0.5%1.12B-3.2%1.15B+4.7%
Goodwill24.0B+4.0%23.1B-2.4%23.7B+3.9%22.8B-1.9%23.2B-2.2%
Intangible assets5.53B-16.9%6.65B-24.6%8.81B-15.7%10.5B-17.9%12.7B-13.8%
Long-term investments918M+3.6%886M+10.9%799M+4.3%766M-6.1%816M-0.6%
16.5B+16.5%14.2B+2.3%13.8B-10.6%15.5B+18.2%13.1B+10.1%
Accounts payable4.24B+1.1%4.20B-2.3%4.29B-6.8%4.61B+4.5%4.41B+11.7%
Short-term & current debt3.03B+102.2%1.50B+38.9%1.08B-52.0%2.25B+198.5%754M+10671.4%
Current lease liability276M+8.7%254M+3.7%245M+6.5%230M-6.1%245M+1.7%
Long-term debt9.90B-21.6%12.6B-7.2%13.6B-6.4%14.5B-16.0%17.3B-6.6%
Non-current lease liability931M+3.9%896M-5.6%949M+0.6%943M-1.4%956M+6.0%
Operating lease liability (total)1.21B+5.0%1.15B-3.7%1.19B+1.8%1.17B-2.3%1.20B+5.1%
Other non-current liabilities2.54B-1.9%2.59B-25.4%3.47B-8.9%3.80B+3.2%3.69B
52.1B+9.4%47.7B+23.5%38.6B+5.2%36.7B+2.5%35.8B+9.2%
Preferred stock0.000.000.000.000.00
Common stock25.5B+1.5%25.2B+1.1%24.9B+0.6%24.7B+1.0%24.5B+1.3%
Retained earnings49.8B+5.3%47.3B+25.8%37.6B+6.5%35.3B+11.8%31.5B+14.1%
Treasury stock17.2B+2.0%16.8B+5.4%16.0B+4.9%15.2B+28.8%11.8B+17.7%
Accumulated other comprehensive income-6.00B+24.1%-7.91B-0.9%-7.84B+2.6%-8.05B+3.9%-8.37B+6.4%
Non-controlling interest641M+170.5%237M+5.8%224M+2.3%219M-1.4%222M+1.4%
Total equity incl. non-controlling52.8B+10.2%47.9B+23.4%38.8B+5.2%36.9B+2.4%36.0B+9.2%
Total liabilities & equity86.7B+6.5%81.4B+11.2%73.2B-1.6%74.4B-1.0%75.2B+3.6%
Common shares issued2.00B+0.3%1.99B+0.2%1.99B+0.1%1.99B+0.1%1.99B+0.2%
Common shares outstanding2.00B+0.3%1.99B+0.2%1.99B+0.1%1.99B+0.1%1.99B+0.2%
Shares outstanding (cover)1.74B+0.2%1.73B-0.0%1.74B-0.2%1.74B-1.4%1.76B-0.5%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
9.57B+11.8%8.56B+17.9%7.26B-24.2%9.58B-9.0%10.5B+33.3%
Depreciation & amortization3.12B-3.2%3.22B-0.8%3.24B-0.7%3.27B-7.7%3.54B+6.3%
Intangible amortization1.68B-10.4%1.88B-4.5%1.97B-2.3%2.01B-1.7%2.05B-4.0%
Share-based compensation664M-1.3%673M+4.5%644M-6.0%685M+7.0%640M+17.2%
Deferred income taxes441M+105.5%-7.96B-1626.9%-461M+30.0%-659M-29.5%-509M-371.3%
Change in receivables652M-5.6%691M+94.1%356M+423.5%68.0M-82.2%383M-58.5%
Change in inventory-195M-436.2%58.0M-75.0%232M-83.6%1.41B+209.9%456M-7.5%
-2.42B-3.6%-2.34B+25.4%-3.13B-80.1%-1.74B+13.3%-2.01B+9.3%
Capital expenditure2.17B-1.6%2.21B+0.2%2.20B+23.9%1.78B-5.7%1.89B-13.4%
Free cash flow7.39B+16.4%6.35B+25.5%5.06B-35.2%7.80B-9.8%8.65B+51.1%
Acquisitions0.000.000.000.000.00
Purchases of investments167M-1.2%169M+6.3%159M-14.1%185M+6.9%173M+108.4%
Other investing activities-18.0M-100.0%-9.00M+59.1%-22.0M+0.0%-22.0M+15.4%-26.0M-36.8%
-6.31B-16.7%-5.40B+23.8%-7.09B+7.1%-7.64B-39.0%-5.49B-97.7%
Long-term debt issued0.000.000.000.00-100.0%4.00M-99.7%
Long-term debt repaid0.000.000.000.00-100.0%48.0M-96.4%
Net short-term debt-115M-15.0%-100M-576.2%21.0M-55.3%47.0M+123.0%-204M-10300.0%
Common stock issued0.000.000.000.000.00
Common stock repurchased893M-31.0%1.29B+5.5%1.23B-67.7%3.79B+65.1%2.30B+470.5%
Dividends paid4.12B+7.3%3.84B+7.9%3.56B+7.5%3.31B+3.3%3.20B+25.1%
Other financing activities-82.0M0.000.000.000.00+100.0%
Net change in cash906M+25.8%720M+124.1%-2.99B-3697.6%83.0M-97.2%2.96B-0.6%
Interest paid545M-9.8%604M-8.8%662M+17.6%563M+3.5%544M-0.9%
Income taxes paid1.93B+12.2%1.72B+16.8%1.48B-20.9%1.86B-4.0%1.94B+100.1%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap218B+11.0%196B+2.7%191B-0.2%191B-22.9%248B+28.0%
P/E33.4×+128.0%14.6×-60.5%37.0×+52.6%24.3×-30.9%35.1×-18.7%
P/S4.9×+5.0%4.7×-2.2%4.8×+12.5%4.3×-26.2%5.8×+2.8%
P/B4.2×+1.5%4.1×-19.3%5.1×-5.0%5.4×-22.6%6.9×+17.2%
P/FCF29.4×-4.7%30.9×-27.4%42.5×+89.8%22.4×-21.9%28.7×-15.3%
Earnings yield3.0%-56.1%6.8%+152.9%2.7%-34.5%4.1%+44.7%2.8%+22.9%
FCF yield3.4%+4.9%3.2%+37.7%2.4%-47.3%4.5%+28.0%3.5%+18.1%
Dividend yield1.9%-3.3%2.0%+4.8%1.9%+8.1%1.7%+35.6%1.3%-2.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: ABT’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ABT filings on SEC EDGAR → Not investment advice.